Search bioRxiv⌕ Search

bioRxiv · 10.1101/818047

Sensitivity and uncertainty analysis of two human atrial cardiac cell models using Gaussian process emulators

Abstract

Cardiac cell models reconstruct the action potential and calcium dynamics of cardiac myocytes, and are becoming widely used research tools. These models are highly detailed, with many parameters in the equations that describe current flow through ion channels, pumps, and exchangers in the cell membrane, and so it is difficult to link changes in model inputs to model behaviours. The aim of the present study was to undertake sensitivity and uncertainty analysis of two models of the human atrial action potential. We used Gaussian processes to emulate the way that 11 features of the action potential and calcium transient produced by each model depended on a set of. The emulators were trained by maximising likelihood conditional on a set of design data, obtained from 300 model evaluations. For each model evaluation, the set of inputs was obtained from uniform distributions centred on the default values for each parameter, using latin-hypercube sampling. First order and total effect sensitivity indices were calculated for each combination of input and output. First order indices were well correlated with the square root of sensitivity indices obtained by partial least squares regression of the design data. The sensitivity indices highlighted a difference in the balance of inward and outward currents during the plateau phase of the action potential in each model, with the consequence that changes to one parameter can have opposite effects in the two models. Overall the interactions among inputs were not as important as the first order effects, indicating that model parameters tend to have independent effects on the model outputs. This study has shown that Gaussian process emulators are an effective tool for sensitivity and uncertainty analysis of cardiac cell models.\n\nAuthor summaryThe time course of the cardiac action potential is determined by the balance of inward and outward currents across the cell membrane, and these in turn depend on dynamic behaviour of ion channels, pumps and exchangers in the cell membrane. Cardiac cell models reconstruct the action potential by representing transmembrane current as a set of stiff and nonlinear ordinary differential equations. These models capture biophysical detail, but are complex and have large numbers of parameters, so cause and effect relationships are difficult to identify. In recent years there has been an increasing interest in uncertainty and variability in computational models, and a number of tools have been developed. In this study we have used one of these tools, Gaussian process emulators, to compare and contrast two models of the human atrial action potential. We obtained sensitivity indices based on the proportion of variance in a model output that is accounted for by variance in each of the model parameters. These sensitivity indices highlighted the model parameters that had the most influence on the model outputs, and provided a means to make a quantitative comparison between the models.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Coveney, S., Clayton, R. H.. 2019-10-24. Sensitivity and uncertainty analysis of two human atrial cardiac cell models using Gaussian process emulators. https://doi.org/10.1101/818047

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗

Matrix Gla Protein deficiency reveals a previously unrecognized mucosal calcification in the mouse airways

Tracheal calcification is a common finding that is considered to have limited clinical significance when detected most often in elderly individuals. Despite its frequent occurrence, the cellular and molecular mechanisms at the origin of tracheal calcification remain largely unexplored. In this context, we aimed to characterize the development of tracheal calcification, and to determine the role of matrix Gla protein (MGP), a major inhibitor of ectopic calcification whose genetic or pharmacologic deficiency is associated with premature tracheal calcification in humans. We found that wild-type mice undergo an unexpected early physiologic calcification of the tracheal cartilage rings beginning around one month after birth. This calcification progresses in a dynamic rostro-caudal sequence through a process involving terminal differentiation of tracheal chondrocytes. These findings challenge the prevailing view that tracheal cartilage is a permanent hyaline cartilage and instead reveals an early and highly organized physiologic calcification process. Furthermore, our findings further identify MGP as a key regulator of calcification within the respiratory tract. Indeed, MGP deficiency not only markedly accelerates tracheal cartilage calcification through a similar pattern and mechanism but also induces a previously unrecognized calcification of the tracheal mucosa, a lesion absent in wild-type mice. These alterations could partly explain the respiratory manifestations observed in MGP-deficient patients having Keutel syndrome, which include dyspnea, cough, stridor, and recurrent infections, symptoms previously being mainly attributed to calcification of the tracheal cartilage rings.

cell biology↗